This post is presented by our media partner Psychedelic News Wire
View the original article here.
A combined study by the University of Colombia and Michigan has revealed an increase in non-LSD psychedelic use by young adult Americans. The poll found that the number of young adults aged 19–30 who use psychedelics other than LSD in the past 12 months doubled from 2018 to 2021.
The study indicated that 3.4% of young adults had used non-LSD psychedelics in 2018 while 6.6% of adults in the same age group had used non-LSD hallucinogens in the past 12 months. Megan Patrick, a research professor from the Survey Research Center at U-M’s Institute for Social Research, coprincipal investigator of the Monitoring the Future study, and study coauthor, noted that non-LSD psychedelic use is “significantly less prevalent” than the use of drugs such as cannabis and alcohol.
Patrick noted that non-LSD psychedelic use increased while LSD use remained at 4% between 2018 and 2021. She also said that the increase in non-LSD was a dramatic increase in drug use that represented “possible public health concerns.” The Monitoring the Future study was funded by the National Institute on Drug Abuse and run by professors from the U-M Institute for Social Research.
Psychedelics have been illegal in most territories for the past several decades but have remained popular among niche users due to their hallucinatory effects. Drugs such as psilocybin (magic mushrooms) and LSD are the most popular among users. A resurgence in psychedelic research has now revealed that these substances have several potential therapeutic applications and significantly increased interest in both classic and alternative psychedelics.
For the study, researchers monitored annual samples of second-grade students from childhood to adulthood with a focus on health and drug use. They analyzed non-LSD hallucinogen use by sex and discovered that males used these specific psychedelics at higher rates, with young white males having higher-use rates than young Black adults. The use of non-LSD hallucinogens was also higher among young adults whose parents went to college.
Although the study did not identify whether the increased use of these psychedelics was due to recreational or medical use, the study notes that prior research has connected recreational psychedelic use with a variety of substance use disorders.
Katherine Keyes, lead study author and professor of epidemiology at Columbia Mailman School, says that the therapeutic use of psychedelics is also on the rise, partly due to research data from recent studies into psychedelics. Still, she cautioned that the enhanced visibility of psychedelics in recent years may be accompanied by unregulated products and a lack of public education on the risks of using psychedelics.
The growing interest in the therapeutic potential of psychedelics suggests that startups such as Seelos Therapeutics Inc. (NASDAQ: SEEL) could have a huge market to serve once their drug-development pipelines yield FDA-approved medicines for different conditions.
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
This post was originally published by our media partner here.
